Journals / Dicle Tıp Dergisi / 2011 / Cilt: 38 - Sayı: 1

Can Propranolol be used as the first line treatment in infantile hemangioma?

Propranolol infantil hemanjiomda birinci basamak tedavisi olarak kullanılabilir mi?

Pages
95–97
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We suggest that propranolol can be considered as a first line treatment in a patient with infantil hemangioma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hemangiomas are the most common tumors of infancy.
📊
Key Findings & Data:We reported a 6-month-old infant presented with a 6-week history of a rapidly growing cutaneus hemangioma on the right eyelid and caused visual impairment.
💡
Conclusion & Impact:We suggest that propranolol can be considered as a first line treatment in a patient with infantil hemangioma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hemangiomas are the most common tumors of infancy. Most of them require no treatment, but treatment is needed if dramatic aesthetic, and/or functional impairment as visual or airway obstruction or ulceration arises. We reported a 6-month-old infant presented with a 6-week history of a rapidly growing cutaneus hemangioma on the right eyelid and caused visual impairment. The patient was successfully treated with the use of oral propranolol therapy. We suggest that propranolol can be considered as a first line treatment in a patient with infantil hemangioma.

Özet

Hemanjiomlar bebeklerde en sık rastlanılan tümörlerdir. Çoğunda tedavi gerekmez ancak, estetik problemlere, görme kaybı ve hava yolu tıkanıklığı gibi fonksiyonel bozukluklara neden oluyorsa ya da ülserasyon gelişmiş ise tedavi gerekmektedir. Bu makalede sağ göz kapağında hızlı büyüyen ve gözünün tamamını kapatarak görme kaybına neden olan kutanöz hemanjiomu olan 6 aylık hastanın oral propranolol ile başarılı bir şekilde tedavi olması nedeni ile sunduk. İnfantil hemanjiom olgularında propranololun birinci basamak tedavi olarak düşünülebileceğini öneriyoruz.

🔖

Cite This Article

TORUN, Y. A., ERGÜL, A. B., DURSUN, İ. (2011). Can Propranolol be used as the first line treatment in infantile hemangioma?. Dicle Tıp Dergisi, Cilt: 38 - Sayı: 1, 95–97. https://ajindex.com/articles/349849

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008; 122:360-367
  2. Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol 2010; 74:338-342 3. Denoyelle F, Leboulanger N, Enjolras O, et al. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009; 73: 1168-1172
  3. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651
  4. Léauté-Labrèze C, Taïeb A. Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann Dermatol Venereol 2008; 135: 860-862
  5. Annabi B, Lachambre MP, Plouffe K, et al. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res 2009; 60: 438-445
  6. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008; 359: 2846-2847.